Nodule
|
phenotype |
|
Acquired Abnormality
|
278
|
19
|
0.010 |
None |
1.000 |
1 |
|
2000 |
2000 |
Systolic Pressure
|
phenotype |
|
Clinical Attribute
|
843
|
1931
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Glomerular Filtration Rate
|
phenotype |
|
Diagnostic Procedure
|
399
|
1033
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Polycystic Kidney Diseases
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
276
|
54
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Polycystic Ovary Syndrome
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
988
|
363
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Skin lesion
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
563
|
52
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Ichthyosis, X-Linked
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
199
|
10
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Sclerocystic Ovaries
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
144
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cardiomyopathy, Familial Idiopathic
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
773
|
243
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Steroid Sulfatase Deficiency Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
181
|
5
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
166
|
374
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
disease |
|
Finding
|
166
|
370
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
phenotype |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
disease |
|
Finding
|
166
|
373
|
0.100 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Clear Cell Sarcoma of Soft Tissue
|
disease |
Neoplasms
|
Neoplastic Process
|
51
|
2
|
0.400 |
None |
0.977 |
44 |
|
1993 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
20 |
|
1995 |
2019 |
Histiocytoma, Angiomatoid Fibrous
|
disease |
Neoplasms
|
Neoplastic Process
|
28
|
|
0.100 |
None |
0.938 |
16 |
|
2000 |
2019 |
melanoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3087
|
515
|
0.100 |
None |
1.000 |
12 |
|
2003 |
2011 |
Sarcoma
|
group |
Neoplasms
|
Neoplastic Process
|
853
|
42
|
0.080 |
None |
1.000 |
8 |
|
2003 |
2019 |
Ewings sarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
517
|
25
|
0.060 |
None |
0.833 |
6 |
|
1995 |
2019 |
Malignant neoplasm of soft tissue
|
group |
Neoplasms
|
Neoplastic Process
|
699
|
32
|
0.050 |
None |
1.000 |
5 |
|
2012 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.040 |
None |
1.000 |
4 |
2
|
2001 |
2019 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.130 |
None |
1.000 |
4 |
5
|
2015 |
2019 |
Adenocarcinoma, Clear Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
117
|
6
|
0.040 |
None |
1.000 |
4 |
|
2011 |
2018 |